# EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis

> **NCT03042104** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Edwards Lifesciences** · enrollment: 901 (actual)

## Conditions studied

- Heart Diseases
- Aortic Stenosis, Severe

## Interventions

- **DEVICE:** Edwards SAPIEN 3 / SAPIEN 3 Ultra THV

## Key facts

- **NCT ID:** NCT03042104
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-07-12
- **Primary completion:** 2024-03-31
- **Final completion:** 2032-03
- **Target enrollment:** 901 (ACTUAL)
- **Last updated:** 2024-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03042104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03042104, "EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03042104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*